How HRS-1301 Affects Body Processing of Two Common Drugs
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests how a new drug called HRS-1301 changes the way your body processes two common medications: midazolam (a sedative) and atorvastatin (a cholesterol drug). Healthy volunteers help researchers understand drug safety and interactions before testing in patients with illness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old
- Your BMI (body size measurement) is between 19.0 and 28, and you weigh at least 50 kg (men) or 45 kg (women)
- All your medical tests, heart rhythm, and imaging scans are normal or show nothing concerning
- You have not taken any medications in the past 2 weeks
- You have not participated in another drug trial in the past 3 months
- You have not donated blood or had significant blood loss in the past 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new tablet, HRS-1301, to see how it is processed by the body in people with different levels of kidney function. It aims to help doctors understand dosing for patients with kidney impairment.
This study tracks how a new experimental drug (HRS-1780) moves through and leaves your body. Researchers will give you a single dose and measure where it goes and how it's eliminated, which helps them understand if it's safe for future patients.
This trial tests a new investigational drug called HRS-2183 in healthy volunteers to see how safe it is and how the body processes it after a single dose and after multiple doses. It's a first step in studying this potential medicine.
This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.
This study tests different forms of an experimental medicine called HRS-5346 to see how the body absorbs them. It is for healthy people aged 18 to 45, and the results will help decide which version to use in future studies.
This trial is testing how different ways of taking an oral medication (HRS9531) affect the drug levels in the body. It is for healthy men to help find the best dosing conditions for future studies.
Hear when a new Hyperlipidemias trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.